Posts

Artificial intelligence predicts the influence of micro...

Plastic waste and its buildup in nature has become a major environmental concern...

STAT+: Apple Watches are back on sale while federal cou...

In a win for Apple, the U.S. Court of Appeals approved it’s request to continue ...

Quitting alcohol — or even drinking less — reduces risk...

"Even moderate, light drinking increases risk" of cancer, per the author of a ne...

STAT+: Philips pays $2.4 million for allegedly giving k...

Philips Respironics paid $2.4 million to settle allegations that it gave free ma...

STAT+: Cytokinetics heart drug aficamten succeeds in pi...

Cytokinetics heart drug aficamten succeeds in pivotal study.

STAT+: What comes after Wegovy? The quest to eradicate ...

The companies that started an obesity revolution with drugs like Wegovy and Zepb...

Opinion: Remembering Betty Rollin, who told her breast ...

Patient advocate Betty Rollin died as she lived: on her own terms.

Violet CEO on measuring clinician inclusiveness: ‘It’s ...

Violet trains clinicians on identity-centered health care, particularly for pati...

STAT+: 3 FDA staffers to watch in 2024

The FDA has a lot on its plate in 2024 with the reorganizations of its food cent...

Opinion: People with food insecurity deserve better nut...

Food literacy skills and nutrition knowledge make a lifelong impact in improving...

STAT+: 3 issues to watch in pharma in 2024

What are the issues to watch in pharma in 2024? The past is likely prologue.

STAT+: Complications spiked 25% in hospitals bought by ...

Adverse events at hospitals like falls and infections spiked 25% after private e...

Opinion: Does food as medicine help patients with diabe...

Does food as medicine help patients with diabetes? Here’s what a new clinical tr...

STAT+: With Biden finalizing an Apple Watch ban, Apple ...

President Biden finalized an import ban of latest Apple Watches after the ITC de...

STAT+: Bristol Myers will pay $4.1 billion for cancer s...

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, buying into the fast-gr...

STAT+: 3 CRISPR advances to watch in 2024

Approval of the first CRISPR-based medicine paves the way for in vivo therapies,...